Bionix (BNOX) up 316% on PTSD News.

Can't say we'd buy this now, but fun to watch. With a $35 million market cap, it now belongs to the night...

Digital Coaches at Dario (DRIO) Significantly Reduce Depression.

63% of Users Show Significant Improvement After Impact of Digital Coaching and Breathing Exercises as Part of the Dario Health Platform.

Dawson James Securities Small Cap Growth Conference | Jupiter, FL | October 12th

Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference. JUPITER, Fla., Sept. 21, 2023 (GLOBE...

Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.

ENDRA Life Science’s (NDRA) $1.23 Fatty Liver Detector Advances to Next Stage of Review...

Gentleman start your engines! Endra (NDRA) recently announced it has advanced to 'substantive review*' with the U.S. Food...

Is Citius Pharma a Ten Bagger?

As is From $0.80 to $8.00.. One of our favorite Broker/Dealer Analysts thinks it is..
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment...
DarioHealth,

Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.

This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential...

Ranked: The Most Popular Drugs in the U.S.

Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.

Adding Dario Health (DRIO) $2.81 to Watch List.

LIVE QUOTE Adding DarioHealth to Top Stocks of 2023...

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...